Drug intelligence / Profile preview

squill extract

Development stage
Preclinical
Lead developer
Mashhad University of Medical Sciences
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Squill extract is a hydro-alcoholic liquid made from the bulbs of *Drimia maritima* (syn. *Scilla maritima*, *Urginea maritima*), historically used as a herbal remedy and in traditional medicine for conditions such as respiratory illnesses, cough, bronchitis, and as an expectorant, diuretic, and cardiotonic. Its key bioactive constituents include bufadienolide glycosides (such as scillaren, scillarubroside, and scillarenin)[2][5]. Mechanistically, squill extract is thought to act via stimulation of beta-2 adrenergic receptors, inhibition of muscarinic receptors, calcium channel blockade, and potassium channel opening[1]. It has shown anti-inflammatory, antioxidant, antibacterial, and mucus-regulating properties in preclinical and small clinical studies[4]. Squill extract is administered orally (syrup, tablets, tinctures, oxymel) and is sometimes used topically for conditions such as patchy hair loss[3][6]. It is also used in the manufacture of rat poison. Notably, oral use is considered unsafe due to cardiotoxicity and gastrointestinal side effects, and its use is generally limited or restricted in modern clinical practice[6][7].

Brand names
Squill Extract BP
Other names
squill extractsquillDrimia maritima extractUrginea maritima extractIndian squill extractMediterranean squill extractSicilian squill extractred squill extractsea squill extractsea onion extractscilia extractwhite squill extract
02

Targets

ATP1A (Sodium/potassium-transporting ATPase)CaV (Voltage-gated calcium channel protein complex)CHRM3 (M3)

Beyond the preview

Go deeper on squill extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on squill extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call